CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $53,000 | -11.7% | 12,648 | +4.5% | 0.00% | 0.0% |
| Q1 2021 | $60,000 | -80.6% | 12,099 | -61.6% | 0.00% | -70.0% |
| Q3 2020 | $309,000 | -47.8% | 31,506 | -47.1% | 0.01% | -33.3% |
| Q2 2020 | $592,000 | +10.4% | 59,513 | -1.9% | 0.02% | +7.1% |
| Q1 2020 | $536,000 | -34.5% | 60,645 | -31.6% | 0.01% | +27.3% |
| Q4 2019 | $818,000 | +408.1% | 88,702 | +224.0% | 0.01% | +450.0% |
| Q3 2019 | $161,000 | – | 27,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |